AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
IMIPENEM & CILASTATIN
13 registrations across 4 African markets— 12 active
Markets with IMIPENEM & CILASTATIN
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| LASTINEM POWDER; ORAL | 🇿🇼Zimbabwe | NEW AVAKASH INTERNATIONAL | active | Aug 2029 |
| BACQURE 500MG/500MG INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | UNIMED LABORATORIES. | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | SUN PHARMACEUTICA L INDUSTRIES LIMITED | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | PT SAMBE FARMA | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | VENUS REMEDIES LIMITED | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | UNIMED LABORATORIES. | active | — |
| Bacqure Injection | 🇹🇿Tanzania | Sun Pharmaceutical Industries Ltd | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | SUN PHARMACEUTICA L INDUSTRIES LIMITED | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | INFUGEN PHARMA PVT. LTD. | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | PT SAMBE FARMA | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | INFUGEN PHARMA PVT. LTD. | active | — |
| IMIPENEM +
CILASTATIN PARENTERAL
ORDINARY DRY
VIALS | 🇺🇬Uganda | VENUS REMEDIES LIMITED | active | — |
IMIPENEM & CILASTATIN in Africa — Regulatory Overview
IMIPENEM & CILASTATIN is registered across 4 African markets with 13 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Tanzania, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.
Of the 13 registrations, 12 (92%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.